LFT slightly high. There is no pain. No yellowing of the eyes. No weakness. So it is easy to brush it aside. But the liver ...
KNUDSEN WILL BE ON PROBATION FOR 18 MONTHS AND OMAHA PROGRAM HELPING YOUNG ADULTS GET ON THEIR FEET HAS A NEW NAME. PARTNERSHIP FOR HOPE SAYS THEIR LAUNCH PAD HOME PROGRAM IS IN A STRONGER POSITION ...
Apple added that many people abandon New Year's fitness resolutions by the second Friday of January, known as "Quitter's Day," but Apple Watch users appear far more likely to stay on track. An ...
We lead busy lives, and between school, work or spending time with family, it can be tricky to make time for working out, especially when first establishing a regular exercise routine. But keep this ...
Love handles after 50 rarely disappear through effort alone. They stick around because most workouts fail to challenge the muscles that actually wrap, stabilize, and tighten the waist. Long cardio ...
Vir Biotechnology is handing off certain commercial rights for its hepatitis D program to European specialty pharma Norgine in a licensing deal that’s worth up to 550 million euros ($645 million) and ...
Rohan Best previously received funding for projects for the Economic Research Institute for ASEAN and East Asia (ERIA) and the New South Wales government. Over the weekend the federal government ...
Bluejay Therapeutics, a biotechnology startup making a treatment for hepatitis D, is set to be acquired by rare disease drugmaker Mirum Pharmaceuticals in a deal that could be worth as much as $820 ...
Nemours Children’s Health has launched an innovative hospital-at-home program for pediatric patients—the first in the country designed by a freestanding children’s hospital. In the six months since ...
In adults with degenerative meniscal tear and radiographic osteoarthritis, adding standard physical therapy, sham in-clinic visits, or text reminders to a structured home-exercise program does not ...
Massachusetts health care systems are reopening their home hospital programs as the longest government shutdown in American history comes to an end. As a part of its deal to reopen the government, ...
Biotron (ASX: BIT) has reported a major step forward in its Hepatitis B Virus drug development program, confirming robust antiviral activity for its lead compound BIT-HBV001 across two established ...